{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:56:39Z","timestamp":1768636599615,"version":"3.49.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.bbi.2017.09.002","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T13:46:35Z","timestamp":1504878395000},"page":"246-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The impact of murine LRRK2 G2019S transgene overexpression on acute responses to inflammatory challenge"],"prefix":"10.1016","volume":"67","author":[{"given":"Darcy","family":"Litteljohn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Rudyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zach","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Hayley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbi.2017.09.002_b0015","first-page":"541","article-title":"LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanism","volume":"128","author":"Arranz","year":"2015","journal-title":"J Cell Sci."},{"issue":"10","key":"10.1016\/j.bbi.2017.09.002_b0035","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.parkreldis.2010.09.003","article-title":"LRRK2 G2019S mutation in Parkinson\u2019s disease: a neuropsychological and neuropsychiatric study in a large Algerian cohort","volume":"16","author":"Belarbi","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"issue":"5","key":"10.1016\/j.bbi.2017.09.002_b0040","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1042\/BST20120124","article-title":"Presynaptic dysfunction in Parkinson\u2019s disease: a focus on LRRK2","volume":"40","author":"Belluzzi","year":"2012","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.bbi.2017.09.002_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-015-0066-z","article-title":"LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate","volume":"11","author":"Belluzzi","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.bbi.2017.09.002_b0050","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13223","article-title":"Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson's disease","volume":"24","author":"Brockmann","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.bbi.2017.09.002_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2047-9158-4-1","article-title":"Meta-analyses on prevalence of selected Parkinson\u2019s nonmotor symptoms before and after diagnosis","volume":"4","author":"Chen","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.bbi.2017.09.002_b0070","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2014.04.021","article-title":"(G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse","volume":"68","author":"Chou","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.bbi.2017.09.002_b0075","first-page":"49","article-title":"LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex","volume":"27","author":"Cirnaru","year":"2014","journal-title":"Front. Mol. Neurosci."},{"issue":"7","key":"10.1016\/j.bbi.2017.09.002_b0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11910-015-0564-y","article-title":"LRRK2 pathways leading to neurodegeneration","volume":"15","author":"Cookson","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2017.09.002_b0085","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0006-8993(92)91106-O","article-title":"Behavioral effects of mouse interferons-alpha and -gamma and human interferon-alpha in mice","volume":"590","author":"Crnic","year":"1992","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.bbi.2017.09.002_b0100","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/cercor\/bhu076","article-title":"Widespread monoaminergic dysregulation of both motor and non-motor circuits in Parkinsonism and Dyskinesia","volume":"25","author":"Engeln","year":"2015","journal-title":"Cereb. Cortex"},{"issue":"1","key":"10.1016\/j.bbi.2017.09.002_b0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuron.2009.11.031","article-title":"Are the dorsal and ventral hippocampus functionally distinct structures?","volume":"65","author":"Fanselow","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bbi.2017.09.002_b0115","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"1997"},{"issue":"4","key":"10.1016\/j.bbi.2017.09.002_b9000","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bbi.2006.12.005","article-title":"Influence of poly I: C on sickness behaviors, plasma cytokines, corticosterone and central monoamine activity: moderation by social stressors","volume":"21","author":"Gandhi","year":"2007","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.bbi.2017.09.002_b9005","doi-asserted-by":"crossref","first-page":"e0118947","DOI":"10.1371\/journal.pone.0118947","article-title":"No dopamine cell loss or changes in cytoskeleton function in transgenic mice expressing physiological levels of wild type or G2019S mutant LRRK2 and in human fibroblasts","volume":"10","author":"Garcia-Miralles","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bbi.2017.09.002_b0120","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.4049\/jimmunol.1000548","article-title":"LRRK2 is involved in the IFN-gamma response and host response to pathogens","volume":"185","author":"Gardet","year":"2010","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bbi.2017.09.002_b0125","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bbi.2007.12.001","article-title":"Synergistic and additive actions of a psychosocial stressor and endotoxin challenge: circulating and brain cytokines, plasma corticosterone and behavioral changes in mice","volume":"22","author":"Gibb","year":"2008","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.bbi.2017.09.002_b0135","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1471-4159.2009.06024.x","article-title":"The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3\/6 and MKK4\/7, in vitro","volume":"109","author":"Gloeckner","year":"2009","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.bbi.2017.09.002_b0140","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.parkreldis.2006.04.001","article-title":"LRRK2 G2019S mutation and Parkinson's disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sample","volume":"12","author":"Goldwurm","year":"2006","journal-title":"Parkinsonism Relat. Disord."},{"issue":"5","key":"10.1016\/j.bbi.2017.09.002_b0150","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00702-011-0653-2","article-title":"Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures","volume":"118","author":"Hakimi","year":"2011","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"13","key":"10.1016\/j.bbi.2017.09.002_b0155","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1523\/JNEUROSCI.19-13-05654.1999","article-title":"Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations","volume":"19","author":"Hayley","year":"1999","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2017.09.002_b0160","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneuroim.2008.03.015","article-title":"Lipopolysaccharide and a social stressor influence behaviour, corticosterone and cytokine levels: divergent actions in cyclooxygenase-2 deficient mice and wild type controls","volume":"197","author":"Hayley","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.bbi.2017.09.002_b0165","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"International LRRK2 Consortium. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.bbi.2017.09.002_b0170","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1471-4159.2006.04246.x","article-title":"Expression and localization of Parkinson\u2019s disease-associated leucine-rich repeat kinase 2 in the mouse brain","volume":"100","author":"Higashi","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2017.09.002_b0190","article-title":"Microglial phenotypes in Parkinson\u2019s disease and animal models of the disease","author":"Joers","year":"2016","journal-title":"Prog. Neurobiol."},{"issue":"7","key":"10.1016\/j.bbi.2017.09.002_b0195","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.parkreldis.2011.04.014","article-title":"Subclinical signs in LRRK2 mutation carriers","volume":"17","author":"Johansen","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.bbi.2017.09.002_b0200","doi-asserted-by":"crossref","first-page":"e34693","DOI":"10.1371\/journal.pone.0034693","article-title":"Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bbi.2017.09.002_b0205","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/jnc.12668","article-title":"Interferon-\u03b3 induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5 in macrophages","volume":"129","author":"Kuss","year":"2014","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.bbi.2017.09.002_b0210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0006-8993(98)01288-8","article-title":"Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects","volume":"818","author":"Lacosta","year":"1999","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.bbi.2017.09.002_b0215","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.neurobiolaging.2014.07.011","article-title":"Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats","volume":"36","author":"Lee","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.bbi.2017.09.002_b0220","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1523\/JNEUROSCI.5604-09.2010","article-title":"Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S","volume":"30","author":"Li","year":"2010","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.bbi.2017.09.002_b0235","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.neuroscience.2009.09.025","article-title":"Interferon-gamma deficiency modifies the motor and co-morbid behavioral pathology and neurochemical changes provoked by the pesticide paraquat","volume":"164","author":"Litteljohn","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2017.09.002_b0240","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-62703-071-7_7","article-title":"Cytokines as potential biomarkers for Parkinson\u2019s disease: a multiplex approach","volume":"934","author":"Litteljohn","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbi.2017.09.002_b0245","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuint.2016.11.005","article-title":"Individual and interactive sex-specific effects of acute restraint and systemic IFN-\u03b3 treatment on neurochemistry","volume":"102","author":"Litteljohn","year":"2017","journal-title":"Neurochem. Int."},{"issue":"8","key":"10.1016\/j.bbi.2017.09.002_b0250","first-page":"391","article-title":"IFN-\u03b3 differentially modulates memory-related processes under basal and chronic stressor conditions","volume":"20","author":"Litteljohn","year":"2014","journal-title":"Front. Cell Neurosci."},{"issue":"8","key":"10.1016\/j.bbi.2017.09.002_b0255","first-page":"316","article-title":"Use of induced pluripotent stem cell derived neurons engineered to express BDNF for modulation of stressor related pathology","volume":"14","author":"Liu","year":"2014","journal-title":"Front. Cell Neurosci."},{"issue":"18","key":"10.1016\/j.bbi.2017.09.002_b0260","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1093\/hmg\/ddv249","article-title":"Selective expression of Parkinson\u2019s disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression","volume":"24","author":"Liu","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbi.2017.09.002_b9010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nbd.2014.07.013","article-title":"Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging","volume":"71","author":"Longo","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.bbi.2017.09.002_b0265","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neurobiolaging.2013.11.018","article-title":"Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson\u2019s disease","volume":"35","author":"Lopez de Maturana","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"16","key":"10.1016\/j.bbi.2017.09.002_b0270","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1093\/hmg\/ddw194","article-title":"LRRK2 modulates microglial activity through regulation of chemokine (C-X3-C) receptor 1 -mediated signalling pathways","volume":"25","author":"Ma","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.bbi.2017.09.002_b0280","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.neurobiolaging.2007.11.020","article-title":"Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: neuroimmune sensitization of neurodegeneration","volume":"30","author":"Mangano","year":"2009","journal-title":"Neurobiol. Aging."},{"issue":"7","key":"10.1016\/j.bbi.2017.09.002_b9015","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.neurobiolaging.2011.02.016","article-title":"Interferon-\u03b3 plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways","volume":"233","author":"Mangano","year":"2012","journal-title":"Neurobiol. Aging."},{"issue":"4","key":"10.1016\/j.bbi.2017.09.002_b0290","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1212\/WNL.0b013e318227042d","article-title":"Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers","volume":"77","author":"Marras","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.bbi.2017.09.002_b0295","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.neuron.2012.08.022","article-title":"LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis","volume":"75","author":"Matta","year":"2012","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.bbi.2017.09.002_b0300","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nbd.2010.07.010","article-title":"Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice","volume":"40","author":"Melrose","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.bbi.2017.09.002_b0305","doi-asserted-by":"crossref","first-page":"e77198","DOI":"10.1371\/journal.pone.0077198","article-title":"LRRK2 affects vesicle trafficking, neurotransmitter extracellular level and membrane receptor localization","volume":"8","author":"Migheli","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bbi.2017.09.002_b0310","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.jnen.0000235121.98052.54","article-title":"LRRK2 expression in normal and pathologic human brain and in human cell lines","volume":"65","author":"Miklossy","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"7","key":"10.1016\/j.bbi.2017.09.002_b0320","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/mds.26213","article-title":"Giladi N; LRRK2 AJ consortium. Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene","volume":"30","author":"Mirelman","year":"2015","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.bbi.2017.09.002_b0325","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1523\/JNEUROSCI.5601-11.2012","article-title":"LRRK2 inhibition attenuates microglial inflammatory responses","volume":"32","author":"Moehle","year":"2012","journal-title":"J. Neurosci."},{"issue":"15","key":"10.1016\/j.bbi.2017.09.002_b0330","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1093\/hmg\/ddv157","article-title":"The G2019S LRRK2 mutation increases myeloid cell chemotactic responses and enhances LRRK2 binding to actin-regulatory proteins","volume":"24","author":"Moehle","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.bbi.2017.09.002_b9020","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5321-06.2007","article-title":"Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons","volume":"27","author":"Mount","year":"2007","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.bbi.2017.09.002_b0340","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","article-title":"Inflammatory process in Parkinson\u2019s disease: role for cytokines","volume":"11","author":"Nagatsu","year":"2005","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.bbi.2017.09.002_b0355","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nn.3636","article-title":"LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity","volume":"17","author":"Parisiadou","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.bbi.2017.09.002_b0370","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1523\/JNEUROSCI.3730-10.2011","article-title":"LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool","volume":"31","author":"Piccoli","year":"2011","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.bbi.2017.09.002_b0375","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/MCB.00914-13","article-title":"Leucine-rich repeat kinase 2 binds to neuronal vesicles through protein interactions mediated by its C-terminal WD40 domain","volume":"34","author":"Piccoli","year":"2014","journal-title":"Mol. Cell Biol."},{"issue":"13","key":"10.1016\/j.bbi.2017.09.002_b0390","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1523\/JNEUROSCI.0650-14.2015","article-title":"Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders","volume":"35","author":"Puccini","year":"2015","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bbi.2017.09.002_b0400","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ynstr.2015.09.001","article-title":"Paraquat and psychological stressor interactions as pertains to Parkinsonian co-morbidity","volume":"12","author":"Rudyk","year":"2015","journal-title":"Neurobiol. Stress"},{"issue":"11","key":"10.1016\/j.bbi.2017.09.002_b0405","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-2094-11-52","article-title":"LRRK2 and neuroinflammation: partners in crime in Parkinson\u2019s disease?","volume":"21","author":"Russo","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bbi.2017.09.002_b0410","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12974-015-0449-7","article-title":"Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-\u03baB p50 signaling in cultured microglia cells","volume":"12","author":"Russo","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2017.09.002_b0415","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/7854_2014_317","article-title":"Clinical and pathological features of Parkinson\u2019s disease","volume":"22","author":"Schneider","year":"2015","journal-title":"Curr. Top Behav. Neurosci."},{"issue":"10","key":"10.1016\/j.bbi.2017.09.002_b0430","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/mds.23746","article-title":"Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinson\u2019s disease","volume":"26","author":"Shanker","year":"2011","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.bbi.2017.09.002_b0435","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.yexcr.2008.02.015","article-title":"LRRK2 regulates synaptic vesicle endocytosis","volume":"314","author":"Shin","year":"2008","journal-title":"Exp. Cell Res."},{"issue":"3","key":"10.1016\/j.bbi.2017.09.002_b0440","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1460-9568.2006.04616.x","article-title":"LRRK2 is expressed in areas affected by Parkinson\u2019s disease in the adult mouse brain","volume":"23","author":"Sim\u00f3n-S\u00e1nchez","year":"2006","journal-title":"Eur. J. Neurosci."},{"issue":"10","key":"10.1016\/j.bbi.2017.09.002_b0450","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nn1776","article-title":"Kinase activity of mutant LRRK2 mediates neuronal toxicity","volume":"9","author":"Smith","year":"2006","journal-title":"Nat. Neurosci."},{"issue":"32","key":"10.1016\/j.bbi.2017.09.002_b0460","doi-asserted-by":"crossref","first-page":"11190","DOI":"10.1523\/JNEUROSCI.0040-15.2015","article-title":"The Parkinson\u2019s disease-associated mutation LRRK2-G2019S impairs synaptic plasticity in mouse hippocampus","volume":"35","author":"Sweet","year":"2015","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2017.09.002_b0465","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1471-4159.2006.03919.x","article-title":"Distribution of PINK1 and LRRK2 in rat and mouse brain","volume":"98","author":"Taymans","year":"2006","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.bbi.2017.09.002_b0470","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1212\/WNL.0b013e3182684646","article-title":"Giladi N; LRRK2 Ashkenazi Jewish Consortium. Lower cognitive performance in healthy G2019S LRRK2 mutation carriers","volume":"79","author":"Thaler","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.bbi.2017.09.002_b0475","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/ejn.13120","article-title":"Intact working memory in non-manifesting LRRK2 carriers \u2013 an fMRI study","volume":"43","author":"Thaler","year":"2016","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.bbi.2017.09.002_b0480","doi-asserted-by":"crossref","first-page":"e21519","DOI":"10.1371\/journal.pone.0021519","article-title":"Regulation of LRRK2 expression points to a functional role in human monocyte maturation","volume":"6","author":"Th\u00e9venet","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bbi.2017.09.002_b0490","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00019052-200108000-00009","article-title":"The role of glial cells in Parkinson\u2019s disease","volume":"14","author":"Vila","year":"2001","journal-title":"Curr. Opin. Neurol."},{"issue":"10","key":"10.1016\/j.bbi.2017.09.002_b0495","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.parkreldis.2015.07.025","article-title":"Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release","volume":"21","author":"Volta","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"46","key":"10.1016\/j.bbi.2017.09.002_b0500","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","article-title":"Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity","volume":"102","author":"West","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.bbi.2017.09.002_b0505","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.nbd.2010.12.008","article-title":"Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice","volume":"41","author":"Winner","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"45","key":"10.1016\/j.bbi.2017.09.002_b0515","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1038\/emm.2013.68","article-title":"LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25","volume":"16","author":"Yun","year":"2013","journal-title":"Exp. Mol. Med."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159117304166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159117304166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:50:18Z","timestamp":1760169018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159117304166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":74,"alternative-id":["S0889159117304166"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2017.09.002","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of murine LRRK2 G2019S transgene overexpression on acute responses to inflammatory challenge","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2017.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}